Taiwan Academy of Tumor Ablation (TATA) Consensus Abstract Hepatocellular carcinoma (HCC) ranks sixth in incidence and third in mortality worldwide, underscoring its public health burden. Ablation therapy is one of the curative treatments for early-stage HCC. With recent advances in systemic therapy, combining ablation with other modalities has demonstrated improved outcomes and has extended applicability to selected patients with intermediate and advanced disease. In paralle

各位會員大家好： Bayer 將舉辦一系列共3場亞太區肝臟影像教育活動，請您與我們一起 Stay Tuned!    年度最終場將於12/15(一) 17:30-19:00(台灣時間)上線 主題: Liver Metastasis 本次會議聚焦: 針對大腸直腸癌與胰臟癌肝轉移病人，EOB MRI 能提供影像判讀及手術決策的重要資訊   歡迎各位會員踴躍報名參加： ☀️ 如需學分 ，請掃描QR code或至表單報名:  Bayer Webinar註冊- 2025/12/15 Liver Metastasis – Fill out form ☀️不需學分，請直接至Zoom會議註冊報名:  Webinar Registration - Zoom   您即可收到報名成功及會議連結(會議前一周/前一天皆會提醒您)，期待在會議上與您一同交流! 主辦單位: 台灣介入放射線學會(TSIR) 教育積分: 台灣介入放射線學會, 台灣腫瘤消融醫學會, 台灣消化系醫學會 學分申請中

Shih-Jer Hsu, MD. MMSc. Department of Internal Medicine and Hepatitis Research Center National Taiwan University Hospital 內容下載

The best care I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add...

The best care I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add...